What is the recommended evaluation and management for a newborn with craniosynostosis and proximal muscle weakness?

Craniosynostosis with Proximal Muscle Weakness in Newborn

This newborn requires immediate evaluation for syndromic craniosynostosis with urgent creatine kinase (CK) testing and genetic workup to rule out a neuromuscular disorder, as the combination of craniosynostosis and proximal muscle weakness is highly atypical and suggests either a syndromic form of craniosynostosis or a concurrent neuromuscular condition like Duchenne muscular dystrophy.

Initial Diagnostic Approach

The presence of both craniosynostosis AND proximal muscle weakness in a newborn is a red flag that demands investigation beyond isolated craniosynostosis:

Immediate Laboratory Testing

• Creatine kinase (CK) level - This is the critical first screening test for neuromuscular disorders 1. Markedly elevated CK (often 10-100x normal) suggests dystrophinopathy or other muscular dystrophy
• If CK is markedly elevated, proceed immediately to dystrophin deletion/duplication testing 1
• Consider metabolic panel including calcium, phosphate, alkaline phosphatase, and thyroid function (secondary causes of craniosynostosis can affect bone metabolism) 2

Clinical Examination Specifics

Look for these key features:

• Craniosynostosis assessment: Palpate all sutures for ridging, assess head shape for characteristic deformities (scaphocephaly, trigonocephaly, plagiocephaly, brachycephaly), measure head circumference 3, 4
• Muscle weakness pattern: Document Gowers' sign (even in infancy), assess tone, check for tongue pseudohypertrophy, evaluate calf hypertrophy 1
• Syndromic features: Examine for midface hypoplasia, proptosis, hand/foot abnormalities (broad thumbs/toes suggest Pfeiffer syndrome; syndactyly suggests Apert syndrome) 2, 5

Imaging Strategy

CT scan is warranted in this case despite general recommendations to limit imaging, because:

• The combination of findings suggests syndromic craniosynostosis requiring surgical planning 4, 6
• Need to assess for multisuture involvement and intracranial anomalies (present in 6% of cases) 7
• Physical examination alone has 6.8% false positive rate for craniosynostosis 7

Genetic Evaluation

Urgent genetics consultation is mandatory given the atypical presentation:

• Syndromic craniosynostosis genetic panel (FGFR1, FGFR2, FGFR3, TWIST1 mutations) 5
• If CK elevated: dystrophin gene testing via multiplex ligation-dependent probe amplification or PCR 1
• Consider chromosomal microarray for unrecognized syndromes

Management Algorithm

If CK is Markedly Elevated (>10x normal):

1. Confirm dystrophinopathy with genetic testing 1
2. If positive, muscle biopsy may be needed to distinguish DMD from milder phenotypes 1
3. Initiate corticosteroid therapy per DMD guidelines
4. Genetic counseling for family members 1
5. Address craniosynostosis surgically if confirmed, but coordinate timing with neuromuscular team

If CK is Normal:

1. Focus on syndromic craniosynostosis workup
2. Investigate alternative causes of hypotonia (metabolic, neurologic)
3. Proceed with craniosynostosis surgical planning if confirmed 6, 8

Referral Pathway

Immediate referrals required:

• Craniofacial surgery/pediatric neurosurgery team 6, 8
• Pediatric neurology or neuromuscular specialist
• Medical genetics
• Pediatric ophthalmology (assess for increased intracranial pressure and syndromic eye findings) 8

Critical Pitfalls to Avoid

• Do not assume isolated craniosynostosis - the muscle weakness changes everything and suggests syndromic disease or dual pathology
• Do not delay CK testing - DMD can present with developmental delays in infancy, and early diagnosis enables earlier intervention 1
• Do not skip imaging - while clinical exam is often sufficient for isolated plagiocephaly 3, this complex presentation requires CT for surgical planning and to identify intracranial anomalies 7
• Do not operate without full workup - anesthetic risk may be significantly elevated if neuromuscular disease is present

Neurodevelopmental Monitoring

Given the dual concerns, establish baseline neurodevelopmental screening using Ages and Stages Questionnaire, with planned reassessment at key developmental milestones 9. Children with craniosynostosis are at increased risk for neurodevelopmental impairment even without concurrent neuromuscular disease 2, 9.